FEops HEARTguide vs FFRct
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
FEops HEARTguide is designed for pre-operative planning of structural heart procedures, using predictive simulations to optimize device sizing and positioning. In contrast, HeartFlow FFRct Analysis is a diagnostic tool that assesses coronary artery disease by creating personalized 3D models from CCTA scans to analyze blood flow. While both are cardiology AI tools leveraging imaging data, their primary applications are distinct: one for surgical planning and the other for non-invasive diagnosis.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
FEops HEARTguide is a cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical measurements to optimize device sizing and positioning for improved patient outcomes. HeartFlow FFRct Analysis is a non-invasive AI-powered diagnostic tool that creates personalized 3D models of coronary arteries from CCTA scans to assess blood flow and aid in diagnosing coronary artery disease.
FEops HEARTguide is designed for advancing personalized care in structural heart disease through predictive simulations, specifically for procedure planning in interventions like TAVI and LAAO. HeartFlow FFRct is used for diagnosing coronary artery disease, helping to guide treatment strategies and revascularization decisions by analyzing blood flow.
Both tools are cloud-based and utilize CT scan data. FEops HEARTguide uses a DICOM interface for CT scan upload, enabling semi-automatic identification and measurement of anatomical landmarks. HeartFlow FFRct creates personalized 3D models from CCTA scans, integrating anatomical and physiological data.
FEops HEARTguide leverages AI, digital twin technology, and predictive simulations for patient-specific replicas and pre-operative evaluation of device interaction with anatomy. HeartFlow FFRct utilizes AI and computational fluid dynamics (CFD) to analyze blood flow and generate FFRct values from CCTA data.
FEops HEARTguide provides predictive simulations, AI-based anatomical measurements, and evaluation of device sizing and positioning pre-operatively. HeartFlow FFRct generates personalized 3D digital models of coronary arteries, analyzes blood flow, and identifies areas of narrowing with FFRct values to help guide treatment.
HeartFlow FFRct has a specified CMS payment rate of $1,017 for 2025, with commercial payer rates varying, and has transitioned to a Category I CPT code. For FEops HEARTguide, pricing information is available upon contact.